Posted: 31 May 2006
EMBO Molecular Medicine Conference: Mammary Gland Development and Breast Cancer Progression
EMBO Conference, UCD, Dublin, Ireland
June 6 - 8, 2006
Studies of how the breast forms and changes during the cycle from birth to puberty have provided considerable insights into the biological nature of breast cancer.
To highlight some of the influential advances in respect of our understanding of mammary gland development and breast cancer progression, investigators at the UCD Conway Institute of Biomolecular and Biomedical Research are organising a European Molecular Biology Organization (EMBO) conference from 6th 8th June 2006 at the OReilly Hall in UCD.
At the conference, world leaders in the field of breast cancer research will present their recent investigations and discoveries to some 200 delegates from across the globe.
René Bernards, Head of the Division of Molecular Carcinogenesis, The
Netherlands Cancer Institute, Amsterdam, will present his research
demonstrating that breast cancer patients with poor prognosis have a
distinctive molecular signature. The power of this molecular signature
to predict disease outcome is much stronger than currently used
diagnostic tools and it is being used to determine the need for
adjuvant chemotherapy in patients with breast cancer. He will also
present work on the large-scale identification of new targets for
cancer treatment.
Ann Chambers from the University of Western Ontario, a world-leader in the study of how cancer cells spread around the body, will outline her work which uses highly advanced, non-invasive imaging approaches to monitor the growth and movement of cancer cells in living model organisms.
Frank Gannon, Executive Director of the European Molecular Biology
Organization (EMBO), Heidelberg, Germany, will highlight how EMBO works
with leading researchers to promote excellence in molecular life
sciences across Europe. He will also describe some key research
regarding the role of proteins that interact with the steroid estrogen
have a role to play in breast cancer and treatment. Frank Gannon is a
native of Galway.
For further information visit the conference website: wwww.targetbreast.com